BioMarin

  • Naglazyme 2018 report

    Naglazyme 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Palynziq 2018 report

    Palynziq 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2018 report

    Vimizim 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Brineura 2017 report

    Brineura 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Kuvan 2017 report

    Kuvan 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2017 report

    Naglazyme 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2017 report

    Vimizim 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kuvan 2016 report

    Kuvan 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2016 report

    Naglazyme 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2016 report

    Vimizim 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kuvan 2015 report

    Kuvan 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2015 report

    Naglazyme 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this Report:...